4HY
[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID
Find entries where: 4HY
is present as a standalone ligand in 13 entries
Chemical Component Summary | |
---|---|
Name | [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID |
Identifiers | 2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid |
Formula | C14 H9 I3 O4 |
Molecular Weight | 621.932 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)O)I)I)O |
InChI | InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20) |
InChIKey | UOWZUVNAGUAEQC-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 30 |
Chiral Atom Count | 0 |
Bond Count | 31 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB03604 |
---|---|
Name | Tiratricol |
Groups | investigational |
Description | A metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome. |
Synonyms |
|
Categories |
|
ATC-Code |
|
CAS number | 51-24-1 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Thyroid hormone receptor beta | MTPNSMTENGLTAWDKPKHCPDREHDWKLVGMSEACLHRKSHSERRSTLK... | unknown | |
Sodium/bile acid cotransporter | MEAHNASAPFNFTLPPNFGKRPTDLALSVILVFMLFFIMLSLGCTMEFSK... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL41632 |
PubChem | 5803 |
ChEMBL | CHEMBL41632 |
CCDC/CSD | ITYAEA10 |